Budget Amount *help |
¥17,290,000 (Direct Cost: ¥13,300,000、Indirect Cost: ¥3,990,000)
Fiscal Year 2018: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥7,410,000 (Direct Cost: ¥5,700,000、Indirect Cost: ¥1,710,000)
|
Outline of Final Research Achievements |
Through our current research project focused on mucosal damage in inflammatory bowel diseases, we found and confirmed a novel endogenous tissue repair system supported by a secretory-type cell population (Atoh1-positive cells) distinct from the genuine intestinal stem cells. In addition, we successfully identified a novel genetic marker, UBD, for the prediction of favorable clinical outcome in response to anti-TNF-a therapy. Expression of UBD was regulated by a synergistic enhancement between the TNF-a pathway and the Notch signaling pathway, as confirmed by experiments using patient-derived intestinal epithelial cells.
|